| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/11/2012 | EP2403503A2 Methods for treating ocular inflammatory diseases |
| 01/11/2012 | EP2403502A1 Medicinal cosmetic lipoatrophy |
| 01/11/2012 | EP2403501A1 Pregnenolone sulfate for the treatment of neurologic disorders |
| 01/11/2012 | EP2403500A2 Stable olanzapine tablets and the process for its preparation |
| 01/11/2012 | EP2403499A2 Methods and compositions useful in treating cancer and reducing wnt mediated effects in a cell |
| 01/11/2012 | EP2403498A2 Enhancing coagulation or reducing fibrinolysis |
| 01/11/2012 | EP2403497A1 Compounds, compositions and use for anticancer therapy |
| 01/11/2012 | EP2403496A1 Compounds and methods for treating cancer and viral infections |
| 01/11/2012 | EP2403495A1 Metadoxine for use as inhibitor of hepatic fibrosis |
| 01/11/2012 | EP2403494A2 Kinase protein binding inhibitors |
| 01/11/2012 | EP2403493A2 Non-steroidal anti-inflammatory ophthalmic compositions |
| 01/11/2012 | EP2403492A1 Use of pyrimidylaminobenzamide derivatives for the treatment of disorders mediated by the leucine zipper- and sterile alpha motif-containing kinase (zak) |
| 01/11/2012 | EP2403491A2 Alkylglycerols and alkoxyglycerols for increasing endogenous plasmalogen levels in mammals |
| 01/11/2012 | EP2403486A1 Sustained release oral dosage forms of an r-baclofen prodrug |
| 01/11/2012 | EP2403485A2 Pharmaceutical composition containing rasagiline mesylate |
| 01/11/2012 | EP2403482A1 Abuse resistant formulation |
| 01/11/2012 | EP2403481A1 Oral dosage forms having a high loading of a gabapentin prodrug |
| 01/11/2012 | EP2403480A1 A process to make fusidic acid cream |
| 01/11/2012 | EP2403478A1 Anionic oil-in-water emulsions containing prostaglandins and uses thereof |
| 01/11/2012 | EP2403477A1 Cationic oil-in-water emulsions containing prostaglandins and uses thereof |
| 01/11/2012 | EP2403476A1 Method of dissolving antifungal agent, and compositions with a high concentration of antifungal agent, suitable for application to the nail |
| 01/11/2012 | EP2403341A1 Lung cancer treatment |
| 01/11/2012 | EP2403340A1 Compounds and compositions for cognition-enhancement, methods of making, and methods of treating |
| 01/11/2012 | EP2403339A1 Combination cancer therapy with an akt inhibitor and other anticancer agents |
| 01/11/2012 | EP2403338A1 Imidazole derivatives useful as modulators of faah and as faah imaging agents |
| 01/11/2012 | EP2403337A2 Alkylsulfonyl-2,3-dihydrospiro[indene-1,4'-piperidine] analogs as glyt1 inhibitors, methods for making same, and use of same in treating psychiatric disorders |
| 01/11/2012 | EP2403335A1 Pharmaceutical composition for delivery of receptor tyrosine kinase inhibiting (rtki) compounds to the eye |
| 01/11/2012 | EP2173737B1 Method for modulating gpr119 g protein-coupled receptor and selected compounds |
| 01/11/2012 | EP2173735B1 Imidazole derivatives as ccr2 receptor antagonists |
| 01/11/2012 | EP2157971B1 Egfr inhibitors for treatment and diagnosis of metastatic prostate cancer |
| 01/11/2012 | EP2152690B1 Pyridyl piperidine orexin receptor antagonists |
| 01/11/2012 | EP2150534B1 Isoquinolinone derivatives as nk3 antagonists |
| 01/11/2012 | EP2131662B1 Process of producing tomato paste |
| 01/11/2012 | EP2084125B1 Aminobenzocycloheptene derivatives, methods for preparing the same and uses thereof in therapy |
| 01/11/2012 | EP2083806B1 Use of an anti-cancer compound |
| 01/11/2012 | EP2066325B1 Pharmaceutical compositions of aripiprazole |
| 01/11/2012 | EP2057127B1 Hydantoin derivatives useful as antibacterial agents |
| 01/11/2012 | EP2044043B1 1- ý[- (2, 4-dimethylphenylsulfanyl) -phenyl]piperazine as a compound with combined serotonin reuptake, 5-ht3 and 5-ht1a activity for the treatment of cognitive impairment |
| 01/11/2012 | EP2037928B1 Methods for treating atherosclerosis |
| 01/11/2012 | EP2027115B1 Dioxaspiroketal derivatives, process for their preparation and uses thereof |
| 01/11/2012 | EP1994005B9 Tetrahydronaphthaline derivatives, methods for the production and use thereof as anti-inflammatory agents |
| 01/11/2012 | EP1991549B1 Bicyclic imidazole or thiadiazole heterocycles useful as selective androgen receptor modulators |
| 01/11/2012 | EP1971339B1 Combination of triazine derivatives and insulin secretion stimulators |
| 01/11/2012 | EP1960369B1 Indanyl-and tetrahydronaphthyl-amino-azoline compounds for combating animal pests |
| 01/11/2012 | EP1959939B1 Use of a3 adenosine receptor agonist in osteoarthritis treatment |
| 01/11/2012 | EP1911454B1 A composition and method of regulating and maintaining the vaginal bacterial flora and the normal acidity in the vagina |
| 01/11/2012 | EP1907350B1 Salt of fumaric acid and 3-(2-dimethylamino)methyl(cyclohex-1-yl))phenol and its crystalline forms |
| 01/11/2012 | EP1891072B1 Substituted 7,8-Dihydro-1H-pyrimido[4,5-b]diazepin-4-amines as kinase inhibitors |
| 01/11/2012 | EP1888066B1 Aminocyclohexanes as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 01/11/2012 | EP1885392B1 Insulins combinations |
| 01/11/2012 | EP1881983B1 Pyrrolopyridines useful as inhibitors of protein kinase |
| 01/11/2012 | EP1869023B1 New tricyclic angiotensin ii agonists |
| 01/11/2012 | EP1868595B1 Compounds for the treatment of metabolic disorders |
| 01/11/2012 | EP1846406B9 Maleimide derivatives, pharmaceutical compositions and methods for treatment of cancer |
| 01/11/2012 | EP1819708B1 Substituted pteridines for treating inflammatory diseases |
| 01/11/2012 | EP1809597B1 Aminoethylaromatic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 01/11/2012 | EP1807094B1 Therapeutic use of cpg oligodeoxynucleotide for skin disease |
| 01/11/2012 | EP1802591B1 Quinazoline derivatives |
| 01/11/2012 | EP1794128B1 Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, their use as a medicament, and a medicament containing them |
| 01/11/2012 | EP1789039B1 S-triazolyl alpha -mercaptoacetanildes as inhibitors of hiv reverse transcriptase |
| 01/11/2012 | EP1765366B1 Use of sulphated depolymerised derivates of exopolysaccharides (eps) as wound healing agents |
| 01/11/2012 | EP1763518B1 Substituted 2-alkyl quinazolinone derivatives as parp inhibitors |
| 01/11/2012 | EP1750703B1 Method for reducing gastrointestinal toxicity due to the administration of tegafur |
| 01/11/2012 | EP1730126B1 Novel benzoxazinone derivatives used as long-acting betamimetics for treating respiratory illnesses |
| 01/11/2012 | EP1609798A9 Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof |
| 01/11/2012 | EP1569904B1 Substituted arylalcanoic acid derivatives as ppar pan agonists with potent antihyperglycemic and antihyperlipidemic activity |
| 01/11/2012 | EP1566380B1 Isoquinoline compounds and medicinal use thereof |
| 01/11/2012 | EP1546343B1 High titer recombinant aav production |
| 01/11/2012 | EP1511845B1 Immunostimulatory oligonucleotides and uses thereof |
| 01/11/2012 | EP1483384B1 Method for overexpression of zwitterionic polysaccharides |
| 01/11/2012 | EP1476081B1 Method and process for producing youthful-appearing, small-pored, and smooth skin |
| 01/11/2012 | EP1458687B1 Pyrimidine compounds as interleukin-12 (il-12) inhibitors |
| 01/11/2012 | EP1402070B1 Methods for the diagnosis of cancer based on the obcam and ntm genes |
| 01/11/2012 | EP1381377B1 A composition including a ginkgolide and apocynin which interferes with the arachidonic acid cascade |
| 01/11/2012 | EP1364044B1 Compositions and methods for detecting pre-cancerous conditions in cell and tissue samples using 5, 10, 15, 20-tetrakis (carboxyphenyl) porphine |
| 01/11/2012 | CN202105076U Knee protective band |
| 01/11/2012 | CN1989140B Compounds containing a n-heteroaryl moiety linked to fused ring moieties for the inhibition of nad(p)h oxidases and platelet activation |
| 01/11/2012 | CN1980925B Substituted azachinazolines having an antiviral action |
| 01/11/2012 | CN1969937B Pharmaceutical composition for treating hepatitis |
| 01/11/2012 | CN1890359B Adhesion inhibition of micro organisms by non-ionic surfactants |
| 01/11/2012 | CN1869058B Method of preparing trialcohol group ginseng saponine and bialcohol group ginseng saponine from notoginseng |
| 01/11/2012 | CN1642542B Angiogenesis inhibitors |
| 01/11/2012 | CN102317475A Template-independent ligation of single-stranded DNA |
| 01/11/2012 | CN102317467A Novel polyamino polyketide antibiotics and uses thereof |
| 01/11/2012 | CN102317435A Equol-producing bacterium and use thereof |
| 01/11/2012 | CN102317302A Bicyclic derivatives of morphine-6-glucuronide, preparation method thereof and use of same in therapeutics |
| 01/11/2012 | CN102317301A Derivatives of morphine-6-glucuronide, preparation method thereof and use of same in therapeutics |
| 01/11/2012 | CN102317296A Fused aromatic PTP-1B inhibitors |
| 01/11/2012 | CN102317293A RAF inhibitors and their uses |
| 01/11/2012 | CN102317291A Fused pyrimidines |
| 01/11/2012 | CN102317290A STAT3 inhibitors and therapeutic methods using the same |
| 01/11/2012 | CN102317289A Lactams as beta secretase inhibitors |
| 01/11/2012 | CN102317288A [1, 2, 4] triazolo [1, 5 -a] pyridines as kinase inhibitors |
| 01/11/2012 | CN102317287A Triazolopyridines as phosphodiesterase inhibitors for treatment of dermal diseases |
| 01/11/2012 | CN102317286A 2-(piperidin-1-yl)-4-heterocyclyl-thiazole-5-carboxylic acid derivatives against bacterial infections |
| 01/11/2012 | CN102317285A 3-aminosulfonyl substituted indole derivatives and methods of use thereof |
| 01/11/2012 | CN102317284A Triazolopyridines as phosphodiesterase inhibitors for treatment of dermal diseases |
| 01/11/2012 | CN102317282A Hetero ring derivative |
| 01/11/2012 | CN102317281A Pyrimidinones as casein kinase ii (CK2) modulators |
| 01/11/2012 | CN102317280A Oxyindole derivatives with motilin receptor agonistic activity |